Description:

ANHL01P1: Secondary Malignancy Report NCT00057811 Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B9F3995A-0FE4-23AE-E034-0003BA12F5E7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B9F3995A-0FE4-23AE-E034-0003BA12F5E7

Keywords:
Versions (3) ▾
  1. 8/27/12
  2. 5/23/15
  3. 6/3/15
Uploaded on:

June 3, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

ANHL01P1: Secondary Malignancy Report NCT00057811

Note: Please send a copy of the pathology report, documenting the secondary malignancy, to the Research Data Center?

Header Module
Diagnosis
Ccrr Module For Anhl01p1: Secondary Malignancy Report

Similar models